DK1682129T3 - N-thiazol-2-ylbenzamidderivater - Google Patents
N-thiazol-2-ylbenzamidderivaterInfo
- Publication number
- DK1682129T3 DK1682129T3 DK04762951T DK04762951T DK1682129T3 DK 1682129 T3 DK1682129 T3 DK 1682129T3 DK 04762951 T DK04762951 T DK 04762951T DK 04762951 T DK04762951 T DK 04762951T DK 1682129 T3 DK1682129 T3 DK 1682129T3
- Authority
- DK
- Denmark
- Prior art keywords
- ylbenzamide
- thiazol
- derivatives
- ylbenzamide derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200301579 | 2003-10-27 | ||
| DKPA200400229 | 2004-02-13 | ||
| PCT/DK2004/000733 WO2005039572A1 (en) | 2003-10-27 | 2004-10-25 | N-thiazol-2-yl-benzamide derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1682129T3 true DK1682129T3 (da) | 2007-06-11 |
Family
ID=34524309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04762951T DK1682129T3 (da) | 2003-10-27 | 2004-10-25 | N-thiazol-2-ylbenzamidderivater |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US20060154974A1 (de) |
| EP (2) | EP1803455A1 (de) |
| JP (1) | JP2007509083A (de) |
| KR (1) | KR20060093726A (de) |
| AR (1) | AR047621A1 (de) |
| AT (1) | ATE354365T1 (de) |
| AU (1) | AU2004283019A1 (de) |
| BR (1) | BRPI0415661A (de) |
| CA (1) | CA2542816A1 (de) |
| CO (1) | CO5690582A2 (de) |
| CY (1) | CY1106526T1 (de) |
| DE (1) | DE602004004925T2 (de) |
| DK (1) | DK1682129T3 (de) |
| EA (2) | EA200801734A1 (de) |
| ES (1) | ES2279414T3 (de) |
| HR (1) | HRP20070194T3 (de) |
| IL (1) | IL175189A0 (de) |
| IS (1) | IS8364A (de) |
| ME (1) | MEP6708A (de) |
| MX (1) | MXPA06004436A (de) |
| NO (1) | NO20062417L (de) |
| PL (1) | PL1682129T3 (de) |
| PT (1) | PT1682129E (de) |
| RS (1) | RS20060289A (de) |
| SG (1) | SG147472A1 (de) |
| SI (1) | SI1682129T1 (de) |
| TW (1) | TW200524887A (de) |
| WO (1) | WO2005039572A1 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060106040A1 (en) | 2002-12-19 | 2006-05-18 | Michael Grzelak | Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders |
| TW200524887A (en) * | 2003-10-27 | 2005-08-01 | Lundbeck & Co As H | N-thiazol-2-yl-benzamide derivatives |
| US7910613B2 (en) | 2004-09-22 | 2011-03-22 | H. Lundbeck A/S | 2-acylaminothiazole derivatives |
| US7674912B2 (en) | 2005-04-25 | 2010-03-09 | H. Lundbeck A/S | Pro-drugs of N-thiazol-2-yl-benzamide derivatives |
| TW200720264A (en) * | 2005-04-25 | 2007-06-01 | Lundbeck & Co As H | Pro-drugs of n-thiazol-2-yl-benzamide derivatives |
| JPWO2006137527A1 (ja) * | 2005-06-23 | 2009-01-22 | 協和発酵キリン株式会社 | チアゾール誘導体 |
| CA2617817C (en) | 2005-08-02 | 2014-05-27 | Kyowa Hakko Kogyo Co., Ltd. | Thiazole derivatives for treating or preventing sleep disorders |
| ES2273599B1 (es) | 2005-10-14 | 2008-06-01 | Universidad De Barcelona | Compuestos para el tratamiento de la fibrilacion auricular. |
| EP2210891A1 (de) * | 2009-01-26 | 2010-07-28 | Domain Therapeutics | Neue Adenosin-Rezeptorliganden und Verwendungen davon |
| GB201106817D0 (en) | 2011-04-21 | 2011-06-01 | Astex Therapeutics Ltd | New compound |
| RU2483722C1 (ru) * | 2012-05-22 | 2013-06-10 | Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" | Аминотиазольные производные усниновой кислоты как новые противотуберкулезные агенты |
| GB201218862D0 (en) | 2012-10-19 | 2012-12-05 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
| GB201218850D0 (en) | 2012-10-19 | 2012-12-05 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
| GB201218864D0 (en) | 2012-10-19 | 2012-12-05 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
| US9980973B2 (en) | 2012-10-19 | 2018-05-29 | Astex Therapeutics Limited | Bicyclic heterocycle compounds and their uses in therapy |
| SG11201604795RA (en) | 2013-12-20 | 2016-07-28 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE855120C (de) * | 1950-10-08 | 1953-01-05 | Schering Ag | Verfahren zur Herstellung von Aminosalicylsaeureamiden |
| JP2903339B2 (ja) * | 1990-10-12 | 1999-06-07 | 大日精化工業株式会社 | 電子写真感光体 |
| US6121301A (en) * | 1996-10-24 | 2000-09-19 | Zeria Pharmaceutical Co., Ltd. | Substituted benzoylaminothiazole derivatives and drugs containing the same |
| GB9823871D0 (en) * | 1998-10-30 | 1998-12-23 | Pharmacia & Upjohn Spa | 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents |
| GB0028383D0 (en) * | 2000-11-21 | 2001-01-03 | Novartis Ag | Organic compounds |
| EP1354880A4 (de) * | 2001-01-26 | 2004-08-25 | Shionogi & Co | Halogenverbindungen, die als agonisten am thrombopoietinrezeptor wirken |
| US7429593B2 (en) * | 2001-09-14 | 2008-09-30 | Shionogi & Co., Ltd. | Utilities of amide compounds |
| US6624163B2 (en) * | 2001-11-29 | 2003-09-23 | Hoffman-La Roche Inc. | Benzothiazole derivatives |
| US6713499B2 (en) * | 2001-12-12 | 2004-03-30 | Hoffman-La Roche Inc. | 7-Amino-benzothiazole derivatives |
| TW200524887A (en) * | 2003-10-27 | 2005-08-01 | Lundbeck & Co As H | N-thiazol-2-yl-benzamide derivatives |
| EP1700856B1 (de) * | 2003-12-26 | 2015-11-11 | Kyowa Hakko Kirin Co., Ltd. | Thiazolderivat |
| US7674912B2 (en) * | 2005-04-25 | 2010-03-09 | H. Lundbeck A/S | Pro-drugs of N-thiazol-2-yl-benzamide derivatives |
-
2004
- 2004-10-08 TW TW093130498A patent/TW200524887A/zh unknown
- 2004-10-21 AR ARP040103822A patent/AR047621A1/es not_active Application Discontinuation
- 2004-10-25 DK DK04762951T patent/DK1682129T3/da active
- 2004-10-25 JP JP2006535952A patent/JP2007509083A/ja not_active Withdrawn
- 2004-10-25 WO PCT/DK2004/000733 patent/WO2005039572A1/en active IP Right Grant
- 2004-10-25 CA CA002542816A patent/CA2542816A1/en not_active Abandoned
- 2004-10-25 RS YUP-2006/0289A patent/RS20060289A/sr unknown
- 2004-10-25 DE DE602004004925T patent/DE602004004925T2/de not_active Expired - Fee Related
- 2004-10-25 PL PL04762951T patent/PL1682129T3/pl unknown
- 2004-10-25 BR BRPI0415661-7A patent/BRPI0415661A/pt not_active IP Right Cessation
- 2004-10-25 SI SI200430225T patent/SI1682129T1/sl unknown
- 2004-10-25 EA EA200801734A patent/EA200801734A1/ru unknown
- 2004-10-25 ME MEP-67/08A patent/MEP6708A/xx unknown
- 2004-10-25 ES ES04762951T patent/ES2279414T3/es active Active
- 2004-10-25 PT PT04762951T patent/PT1682129E/pt unknown
- 2004-10-25 EP EP07102639A patent/EP1803455A1/de not_active Withdrawn
- 2004-10-25 EA EA200600860A patent/EA010790B1/ru not_active IP Right Cessation
- 2004-10-25 EP EP04762951A patent/EP1682129B1/de active Active
- 2004-10-25 AT AT04762951T patent/ATE354365T1/de not_active IP Right Cessation
- 2004-10-25 KR KR1020067008181A patent/KR20060093726A/ko not_active Application Discontinuation
- 2004-10-25 AU AU2004283019A patent/AU2004283019A1/en not_active Abandoned
- 2004-10-25 MX MXPA06004436A patent/MXPA06004436A/es active IP Right Grant
- 2004-10-25 SG SG200807988-1A patent/SG147472A1/en unknown
-
2005
- 2005-12-20 US US11/312,661 patent/US20060154974A1/en not_active Abandoned
-
2006
- 2006-03-20 IS IS8364A patent/IS8364A/is unknown
- 2006-04-25 CO CO06039105A patent/CO5690582A2/es not_active Application Discontinuation
- 2006-04-25 IL IL175189A patent/IL175189A0/en unknown
- 2006-05-26 NO NO20062417A patent/NO20062417L/no not_active Application Discontinuation
-
2007
- 2007-04-19 CY CY20071100529T patent/CY1106526T1/el unknown
- 2007-05-07 HR HR20070194T patent/HRP20070194T3/xx unknown
-
2008
- 2008-12-19 US US12/339,438 patent/US20090247593A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TW200524887A (en) | 2005-08-01 |
| EA200801734A1 (ru) | 2008-12-30 |
| JP2007509083A (ja) | 2007-04-12 |
| KR20060093726A (ko) | 2006-08-25 |
| CY1106526T1 (el) | 2012-01-25 |
| EA010790B1 (ru) | 2008-10-30 |
| HRP20070194T3 (en) | 2007-06-30 |
| US20060154974A1 (en) | 2006-07-13 |
| DE602004004925T2 (de) | 2007-10-31 |
| PT1682129E (pt) | 2007-04-30 |
| MEP6708A (xx) | 2010-02-10 |
| EA200600860A1 (ru) | 2006-08-25 |
| EP1682129A1 (de) | 2006-07-26 |
| DE602004004925D1 (de) | 2007-04-05 |
| EP1803455A1 (de) | 2007-07-04 |
| AU2004283019A1 (en) | 2005-05-06 |
| US20090247593A1 (en) | 2009-10-01 |
| CO5690582A2 (es) | 2006-10-31 |
| NO20062417L (no) | 2006-05-26 |
| PL1682129T3 (pl) | 2007-07-31 |
| EP1682129B1 (de) | 2007-02-21 |
| IL175189A0 (en) | 2006-09-05 |
| WO2005039572A1 (en) | 2005-05-06 |
| CA2542816A1 (en) | 2005-05-06 |
| BRPI0415661A (pt) | 2006-12-19 |
| IS8364A (is) | 2006-03-20 |
| SG147472A1 (en) | 2008-11-28 |
| AR047621A1 (es) | 2006-02-01 |
| ATE354365T1 (de) | 2007-03-15 |
| ES2279414T3 (es) | 2007-08-16 |
| RS20060289A (en) | 2008-06-05 |
| SI1682129T1 (sl) | 2007-06-30 |
| MXPA06004436A (es) | 2006-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE340782T1 (de) | Piperidinbenzolsulfonamidderivate | |
| NO20054136D0 (no) | Imidazol-4-yl-etynyl-pyridin-derivater | |
| ATE420066T1 (de) | Amidoacetonitrilderivate | |
| IS2656B (is) | Nýjar besímídasólafleiður | |
| ATE352550T1 (de) | Chinazolinderivate | |
| ATE478870T1 (de) | Spiroindolinpiperidinderivate | |
| ATE460418T1 (de) | Heterocyclocarboxamidderivate | |
| DK1551802T3 (da) | Indol-3-svovlderivater | |
| ATE467631T1 (de) | Chinuclidinamidderivate | |
| IS7720A (is) | Píperidín-N-oxíð-afleiður | |
| ATE438644T1 (de) | Chinazolinderivate | |
| DK2248807T3 (da) | N-Phenyl-2-pyrimidinaminderivater | |
| DE602004018130D1 (de) | Kaffeeaufbrühvorrichtung | |
| DE602004016801D1 (de) | Weglenkungsüberwachung | |
| IS8364A (is) | N-þíasól-2-ýl-bensamíð afleiður | |
| DE602004029114D1 (de) | Trennanalysator | |
| DE602004010354D1 (de) | Medienwegleitmodul | |
| IS8045A (is) | Púrín-6-ón-afleiður | |
| ATE335729T1 (de) | 3h-chinazoline -4-on derivaten | |
| ATE423771T1 (de) | Tetrahydrochinolinderivate | |
| ATE449064T1 (de) | Amidoacetonitrilderivate | |
| DE602004013661D1 (de) | Spritzgiessnadelverschlussbuchse | |
| DE602004014793D1 (de) | Acrylsolzusammensetzung | |
| DE502004010296D1 (de) | Chromenonindole | |
| DE50306277D1 (de) | 4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate |